Logos Global Management’s Olema Pharmaceuticals OLMA Stock Holding History

Logos Global Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$47.8M	Hold	3,208,875	–	–	2.39%	10
2025 Q4	$80.2M	Hold	3,208,875	–	–	4.85%	4
2025 Q3	$31.4M	Hold	3,208,875	–	–	2.82%	12
2025 Q2	$13.7M	Hold	3,208,875	–	–	1.51%	24
2025 Q1	$12.1M	Hold	3,208,875	–	–	2.14%	18
2024 Q4	$18.7M	Hold	3,208,875	–	–	2.19%	17
2024 Q3	$38.3M	Hold	3,208,875	–	–	4.13%	6
2024 Q2	$34.7M	Sell	3,208,875 -1,175,000	-27%	-$12.7M	2.79%	11
2024 Q1	$49.6M	Hold	4,383,875	–	–	4.02%	8
2023 Q4	$54.4M	Buy	4,383,875 +640,000	+17%	+$8.6M	5.08%	7
2023 Q3	$46.2M	Hold	3,743,875	–	–	6.17%	3
2023 Q2	$33.8M	Hold	3,743,875	–	–	4.6%	6
2023 Q1	$13M	Hold	3,743,875	–	–	1.86%	23
2022 Q4	$9.17M	Hold	3,743,875	–	–	1.07%	26
2022 Q3	$10.3M	Hold	3,743,875	–	–	1.27%	22
2022 Q2	$15.2M	Hold	3,743,875	–	–	2.8%	15
2022 Q1	$15.9M	Hold	3,743,875	–	–	2.07%	20
2021 Q4	$35M	Hold	3,743,875	–	–	3.61%	13
2021 Q3	$103M	Hold	3,743,875	–	–	7.44%	2
2021 Q2	$105M	Hold	3,743,875	–	–	8.8%	2
2021 Q1	$124M	Hold	3,743,875	–	–	12.12%	2
2020 Q4	$180M	Buy	+3,743,875	New	+$176M	15.43%	2

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Logos Global Management's OLMA Position: Q1 2026 in Review

Logos Global Management held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 3,208,875 shares worth $47.8M. The position accounts for 2.39% of the portfolio, ranked #10.

Logos Global Management first reported a position in OLMA in Q4 2020 and has held it in 22 quarters since. The position peaked at $180M in Q4 2020. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Logos Global Management held 3,208,875 shares of Olema Pharmaceuticals worth $47.8M as of Q1 2026.
Logos Global Management left its Olema Pharmaceuticals share count unchanged in Q1 2026.
Olema Pharmaceuticals made up 2.39% of Logos Global Management's portfolio in Q1 2026, its #10 holding.
Logos Global Management first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
Logos Global Management's Olema Pharmaceuticals position peaked at $180M in Q4 2020.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.